Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
On Thursday, the Food and Drug Administration approved the non-opioid pain relievers from Vertex Pharmaceuticals, a new ...
We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at where Alphabet Inc.
A small plane crashed in Philadelphia on Friday evening, causing an explosion and multiple house fires. Former air traffic ...
Healthcare has become the second-best performer in the S&P 500 (SP500) this month, prompting market observers to foresee a brighter 2025 for a sector that has struggled to outperform the broader index ...
What is the significance of topics such as the Ease of Doing Business (EoDB), deregulation, challenges posed by AI, and NIPUN Bharat Mission have on both the UPSC preliminary and main exams? You can ...